CureDuchenne FUTURES National Conference 2022

Complete Coverage

Rare Care podcast logo

An Interview With CureDuchenne Chief Scientific Officer Dr. Michael Kelly

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Michael Kelly, PhD, chief scientific officer at CureDuchenne, on the latest developments in exon skipping, gene therapy, and other treatments for Duchenne muscular dystrophy. Read the full story here: Gene Therapy Could Emerge as a DMD Treatment in 2023
CureDuchenne FUTURES 2022

Rare Disease Advisor is excited to offer coverage of CureDuchenne’s 2022 FUTURES National Conference. The CureDuchenne 2022 FUTURES National Conference is a hybrid virtual/in-person event being held in Orlando, Florida from May 27-29. This year’s conference agenda and special events will focus on Building Community. CureDuchenne will be offering insightful and interactive presentations on a variety of relevant topics, an Exhibitor Showcase, social events for the whole family, e-Gaming experiences, and more.

For registration and program info, visit the FUTURES 2022 info page.

Next post in DMD Features